In Q4 EBITDA margin improved 182 basis points (bps) YoY and 21 bps sequentially at 24.2 per cent.
While investors have preferred to stay on the sidelines on Paytm stock, Goldman Sachs believes the risk-reward for Paytm are skewed to the upside
RITES Q4 results 2022: Operating revenue, excluding other income, went up by 21.5 per cent to Rs 744 crore in Q4 FY22
In Q4FY22, EBITDA margin contracted by 720 basis points (bps) year-on-year to 17.6 per cent.
Easy Trip Planners Ltd on Wednesday reported a 23.4 per cent decline in consolidated net profit at Rs 23.34 crore for the fourth quarter ended March, impacted by lower revenue and higher expenses.
Max Healthcare Institute on Wednesday said its profit after tax increased by 58 per cent to Rs 172 crore for the fourth quarter ended March 2022. The company had reported a net profit of Rs 109 crore for the January-March quarter of 2020-21 fiscal. Gross revenue rose to Rs 1,298 crore for the period under review as compared with Rs 1,161 crore in the year-ago period, Max Healthcare Institute said in a regulatory filing. For the year ended March 31, 2022, the healthcare provider posted a net profit of Rs 837 crore. It had reported a net loss of Rs 95 crore in FY21 fiscal. "Overall, FY22 has been an eventful year where despite numerous challenges, there is a marked improvement in the network performance," Max Healthcare Institute Chairman and MD Abhay Soi said in a statement. As part of the company's inorganic growth strategy, it has announced four transactions, including purchase of two prime land parcels in Gurugram, he noted. "These will have a combined potential to add 2,200 be
Shoemaker Bata India Ltd on Wednesday reported over two-fold increase in its consolidated net profit at Rs 62.96 crore for the fourth quarter ended March 31, 2022.
It had a posted a net profit of Rs 314.66 crore in the January-March quarter a year ago, Colgate-Palmolive India Ltd (CPIL) said in a BSE filing
The broader markets ended with deeper losses, with both the BSE Midcap and Smallcap indices down over 1.5 per cent each; the breadth too at 2:1 was in favour of the bears.
Dr Reddy's Q4 results: The revenue was up 15% to Rs 5,437 crore for the quarter under review
The stock gained 9 per cent in two days after the pharma company reported better-than-expected revenue growth in March quarter (Q4FY22).
The company's consolidated income during the January-March period increased to Rs 4,492.10 crore as against Rs 2,874.47 crore a year ago, the filing said.
The board recommended a dividend of Rs 2 per equity share (of face value of Rs 10) for 2021-22 subject to shareholders' nod
The red line comes amid headwinds in EU operatopns and discontinuation of liquids business in the US; revenue, however, grows by 10%
The company had posted a net profit of Rs 130.06 crore during the March quarter of the previous fiscal, Whirlpool of India, a subsidiary of Whirlpool Corporation said in a regulatory filing.
The management believes that the auto industry is at the cusp of revival, with favorable governmental policies and more new product launches planned by OEMs for the coming year.
Stocks to Watch Today: Sugar and FMCG stocks likely to be in focus as govt limits sugar exports and exempts customs duty on agri cess. Apollo Hospitals, Bata, Coal India and Nalco to report results.
SAIL's consolidated revenue from operations rose 32% to Rs 30,759 cr
The meeting will also consider payment of dividend, if any, LIC said
The Mumbai-based BOI's net interest income (NII) expanded by 35.77 per cent to Rs 3,986 crore in Q4FY22 from Rs 2,936 crore in Q4FY21